ASX:CHK Cohiba Minerals (CHK) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free CHK Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cohiba Minerals alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Cohiba Minerals Stock (ASX:CHK)Cohiba Minerals Limited engages in the exploration of natural resources in Australia. The company explores for metals, precious metals, lithium, cobalt, gypsum, gold, copper, and minerals deposits. It holds 100% interests in the Pyramid Lake project covering an area of 112.66 square kilometers located in Esperance, Western Australia; the Wee MacGregor project comprising three mining licenses located in southeast of Mt. Isa; and the Olympic Domain Tenements consisting of eight exploration licenses covering an area of 831 square kilometer located in South Australia. Cohiba Minerals Limited was incorporated in 2011 and is based in Melbourne, Australia.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> CHK Stock News HeadlinesApril 9, 2024 | thestreet.comChesapeake Energy CorporationJanuary 29, 2024 | msn.comASX Small Caps Lunch Wrap: Who’s come up with a brutal way to get back at your ex on Valentine’s Day?April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 22, 2024 | msn.comTop 10 at 10: Uranium speccies on the rise as wilting lithium developer Liontown sinks below $1December 27, 2023 | msn.comTop 10 at 10: $180m REE deals and one very upset oil and gas playDecember 7, 2023 | msn.comPlacement tips $1.5m into Cohiba’s coffers for new economy minerals explorationDecember 7, 2023 | msn.comIn Case You Missed It: Gold, gas and more gold take the top spotsDecember 5, 2023 | msn.comClosing Bell: Local markets fall into pre-Santa sulk just as RBA says we’re done for nowApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.November 20, 2023 | msn.comTop 10 at 11: Major gains for sustainable ag after Roots flies a shipment out of IsraelOctober 25, 2023 | msn.comTop 10 at 11: Graphite play Greenwing Resources catches rocketSeptember 11, 2023 | msn.comCohiba Minerals dives into field work at Canadian lithium, REE projectsJuly 10, 2023 | msn.comCohiba Minerals gets skates on for explorationApril 16, 2023 | money.usnews.comHow to Endorse a CheckFebruary 7, 2023 | thestreet.comIs Chesapeake Energy Finally Looking Up Again?January 13, 2023 | thestreet.comHow Will Chesapeake Energy (CHK) Stock React To These Racketeering Charges?January 10, 2023 | thestreet.comIcahn Buys 7.6% of Chesapeake Energy, Seeks Major Board ChangeDecember 23, 2022 | forbes.comChesapeake EnergySeptember 26, 2022 | ca.finance.yahoo.comCohiba Minerals Limited (CHKMF)August 14, 2022 | reuters.comCohiba Minerals LtdAugust 11, 2022 | finance.yahoo.comCohiba Minerals Limited (CHK.AX)June 20, 2022 | au.finance.yahoo.comCohiba Minerals Limited (CHK.AX) Major Mineralised fault zone target for Horse Well DrillingJune 13, 2022 | au.finance.yahoo.comCohiba Minerals Limited (CHK.AX) Exploration Update - Horse Well, Pernatty C and arriner CreekMay 28, 2022 | au.finance.yahoo.comCohiba Minerals Limited (CHK.AX) Drilling Resumes at Horse Well ProspectMay 18, 2022 | sg.finance.yahoo.comCohiba Minerals Limited (CHK.AX) Drilling Completed at Warriner Creek ProspectsApril 26, 2022 | au.finance.yahoo.comCohiba Minerals Limited (CHK.AX) Initial Drill Hole Completed at Warriner Creek ProjectApril 4, 2022 | au.finance.yahoo.comCohiba Minerals Limited (CHK.AX) Drilling Commences at Warriner Creek ProspectSee More Headlines Receive CHK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cohiba Minerals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/15/2018Today4/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Other Industrial Metals & Mining Sub-IndustryN/A Current SymbolASX:CHK CUSIPN/A CIKN/A Webcohibaminerals.com.au Phone+61-3-96927222FaxN/AEmployees1,300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,520,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-42.62% Return on Assets-24.25% Debt Debt-to-Equity Ratio0.26 Current Ratio0.94 Quick Ratio3.82 Sales & Book Value Annual Sales$12,331.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.50 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares3,590,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.93 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Mordechai Benedikt (Age 43)Executive Chairman Comp: $228kMr. Andrew GrahamCEO & Executive DirectorMr. Justin Mouchacca B.Bus (Acc)C.A., CA, Company SecretaryKey CompetitorsA-Cap EnergyASX:ACBAccelerate ResourcesASX:AX8Accent ResourcesASX:ACSACDC MetalsASX:ADCAclara ResourcesTSE:ARA.TOView All CompetitorsInsidersMordechai BenediktSold 22,000,000 sharesTotal: $44,000.00 ($0.00/share) CHK Stock Analysis - Frequently Asked Questions How were Cohiba Minerals' earnings last quarter? Cohiba Minerals Limited (ASX:CHK) posted its earnings results on Thursday, March, 15th. The company reported $0.00 earnings per share (EPS) for the quarter. This page (ASX:CHK) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cohiba Minerals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.